TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations

Conditions:   Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations;   Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations Intervention:   Drug: TAS-117 Sponsor:   Taiho Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials